Statistics for Targeting MRP2 in HepG2 Cells Using the CRISPR-Cas9 System to Reverse Oxaliplatin Resistance

Total visits

views
Targeting MRP2 in HepG2 Cells Using the CRISPR-Cas9 System to Reverse Oxaliplatin Resistance 650

Total visits per month

views
November 2023 0
December 2023 4
January 2024 0
February 2024 0
March 2024 0
April 2024 0
May 2024 0

File Visits

views
ZouY.pdf(legacy) 983
ZouY.pdf 206

Top country views

views
United States 252
New Zealand 158
China 25
France 25
Ireland 17
Iran 16
Canada 12
Belgium 9
Australia 8
Germany 8
Turkey 8
United Kingdom 7
Sweden 7
South Korea 5
Egypt 4
India 4
Vietnam 4
Finland 3
Hong Kong SAR China 3
Italy 3
Seychelles 3
Singapore 3
Taiwan 3
Cuba 2
Czechia 2
Algeria 2
Greece 2
Hungary 2
Mexico 2
Malaysia 2
Poland 2
Brazil 1
Israel 1
Iraq 1
Netherlands 1
Pakistan 1
Russia 1
Thailand 1

Top city views

views
Auckland 124
Redwood City 57
Fairfax 41
Buffalo 33
Chicago 23
Dublin 16
Louisville 11
Ashburn 10
Menlo Park 7
Montréal 7
Mountain View 6
Alameda 5
Sydney 5
Antwerpen 4
Guangzhou 4
Hamilton 4
Hanoi 4
San Diego 4
Wellington 4
Cairo 3
Dunedin 3
Hangzhou 3
Istanbul 3
Palmerston North 3
Salem 3
Stockholm 3
Toronto 3
Aalst 2
Andover 2
Ankara 2
Boardman 2
Cambridge 2
Central District 2
Changi 2
Hyderabad 2
Kusatsu 2
La Habana 2
Lawrence 2
Mashhad 2
Montesilvano 2
Nanjing 2
Nezahualcóyotl 2
Phoenix 2
Seoul 2
Surbiton 2
Wuhan 2
Würzburg 2
Zhengzhou 2
Åkersberga 2
Arlington 1
Athens 1
Blue Bell 1
Brasschaat 1
Brookings 1
Brussels 1
Budapest 1
Bundoora 1
Changhua 1
Chapel Hill 1
Chennai 1
Chevy Chase 1
Chongqing 1
Christchurch 1
Cincinnati 1
Cold Spring Harbor 1
Columbus 1
Cork 1
Delhi 1
Des Moines 1
Düsseldorf 1
Edinburgh 1
Erbil 1
Esfahan 1
Espoo 1
Evanston 1
Fuzhou 1
Gainesville 1
Groningen 1
Gîza 1
Harbin 1
Huntsville 1
Irvine 1
Izmir 1
Jiaxing 1
Khon Kaen 1
Kiel 1
Kobe 1
Kogarah 1
Kowloon 1
Kuantan 1
Kunming 1
Kyoto 1
La Jolla 1
Lahore 1
Llangefni 1
Massapequa 1
Matamata 1
Minneapolis 1
Nelson 1
New York 1